Imatinib administration in two patients with liver metastases from GIST and severe jaundice

por De Pas, T, Danesi, R, Catania, C, Curigliano, G, de Braud, F
Publicado 2003

Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy

por Fucà, G., Spagnoletti, A., Ambrosini, M., de Braud, F., Di Nicola, M.
Publicado 2021

Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group

por De Pas, T, Bodei, L, Pelosi, G, de Braud, F, Villa, G, Capanna, R, Paganelli, G
Publicado 2003

Neuroendocrine tumour arising inside a retro-rectal tailgut cyst: report of two cases and a review of the literature

por Spada, F, Pelosi, G, Squadroni, M, Lorizzo, K, Farris, A, de Braud, F, Fazio, N
Publicado 2011

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies

por Procopio, G, Verzoni, E, Iacovelli, R, Biasoni, D, Testa, I, Porcu, L, De Braud, F
Publicado 2012

Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma

por De Pas, T, Spitaleri, G, Vigna, PD, Toffalorio, F, Curigliano, G, Gambino, A, Boselli, S, Catania, C, de Braud, F
Publicado 2008

QTc prolongation assessment in anticancer drug development: clinical and methodological issues

por Curigliano, G, Spitaleri, G, de Braud, F, Cardinale, D, Cipolla, C, Civelli, M, Colombo, N, Colombo, A, Locatelli, M, Goldhirsch, A
Publicado 2009

Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

por Stahel, R, Rossi, A, Petruzelka, L, Kosimidis, P, de Braud, F, Bernardo, M M, Souquet, P-J, Parra, H Soto, Gridelli, C
Publicado 2003

1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study

por Nichetti, F., Bini, M., Dotti, K.F., Ottini, A., Ambrosini, M., Rametta, A., Leporati, R., Ferrari, L., De Braud, F.G.M.
Publicado 2020

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.

por Janot, F., Klijanienko, J., Russo, A., Mamet, J. P., de Braud, F., El-Naggar, A. K., Pignon, J. P., Luboinski, B., Cvitkovic, E.
Publicado 1996

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma

por Santoro, A, Pressiani, T, Citterio, G, Rossoni, G, Donadoni, G, Pozzi, F, Rimassa, L, Personeni, N, Bozzarelli, S, Rossoni, G, Colombi, S, De Braud, F G, Caligaris-Cappio, F, Lambiase, A, Bordignon, C
Publicado 2010

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

por Joensuu, H, De Braud, F, Grignagni, G, De Pas, T, Spitalieri, G, Coco, P, Spreafico, C, Boselli, S, Toffalorio, F, Bono, P, Jalava, T, Kappeler, C, Aglietta, M, Laurent, D, Casali, P G
Publicado 2011

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population

por Westphalen, C. B., Krebs, M. G., Le Tourneau, C., Sokol, E. S., Maund, S. L., Wilson, T. R., Jin, D. X., Newberg, J. Y., Fabrizio, D., Veronese, L., Thomas, M., de Braud, F.
Publicado 2021

Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population

por Westphalen, C. B., Krebs, M. G., Le Tourneau, C., Sokol, E. S., Maund, S. L., Wilson, T. R., Jin, D. X., Newberg, J. Y., Fabrizio, D., Veronese, L., Thomas, M., de Braud, F.
Publicado 2021

1647TiP Antiandrogen therapy and TMPRSS2 status: How prostate cancer patients are protected from COVID-19 pandemic

por Claps, M., Jachetti, E., Ferri, R., Badenchini, F., Verzoni, E., Montone, R., Sepe, P., Guadalupi, V., Ottini, A., Baciarello, G., Valdagni, R., Colombo, M.P., de Braud, F., Procopio, G.
Publicado 2021

Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumors

por Lobefaro, R., Rota, S., Porcu, L., Brunelli, C., Alfieri, S., Zito, E., Taglialatela, I., Ambrosini, M., Spagnoletti, A., Zimatore, M., Fatuzzo, G., Lavecchia, F., Borreani, C., Apolone, G., De Braud, F., Platania, M.
Publicado 2022

Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA

por La Rocca, E., De Santis, M. C., Silvestri, M., Ortolan, E., Valenti, M., Folli, S., de Braud, F. G., Bianchi, G. V., Scaperrotta, G. P., Apolone, G., Daidone, M. G., Cappelletti, V., Pruneri, G., Di Cosimo, S.
Publicado 2022

Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy

por Ortolan, E., Appierto, V., Silvestri, M., Miceli, R., Veneroni, S., Folli, S., Pruneri, G., Vingiani, A., Belfiore, A., Cappelletti, V., Vismara, M., Dell'Angelo, F., De Cecco, L., Bianchi, G.V., de Braud, F.G., Daidone, M.G., Di Cosimo, S.
Publicado 2021

Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology

por Biffi, R, Orsi, F, Zampino, MG, Chiappa, A, Fazio, N, De Braud, F, Bonomo, G, Monfardini, L, Vigna, PD, Luca, F, Bodei, L, Bartolomei, M, Catalano, G, Leonardi, MC, Ferrari, M, Andreoni, B, Goldhirsch, A, Paganelli, G, Orecchia, R
Publicado 2008

Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognost...

por Necchi, A, Pennati, M, Zaffaroni, N, Landoni, E, Giannatempo, P, Raggi, D, Schwartz, L H, Morosi, C, Crippa, F, Farè, E, Nicolai, N, Lanocita, R, Sava, T, Sacco, C, Messina, C, Ortega, C, De Braud, F G, Salvioni, R, Daidone, M G, Gianni, A M, Mariani, L
Publicado 2014